Award

Delivery Order #SPE2DR26F9QM9

Delivery Order for Pharmaceutical Suspension Under Long-Term AmerisourceBergen Contract

Buyer

Defense Logistics Agency

Award Amount

$995.21

Ceiling

$995.21

Awarded

February 11, 2026

Period of Performance

Feb 11, 2026 – Feb 12, 2026

Identifier

SPE2DR26F9QM9

NAICS

424210

This award represents a delivery order contract issued to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company. The order involves the supply of a specific pharmaceutical product, Quillivant XR 25 mg/5 ml suspension, which is used in medical treatments requiring this medication. The contract is a short-term delivery order executed under a broader indefinite delivery vehicle with AmerisourceBergen, supporting ongoing pharmaceutical procurement for healthcare facilities. This delivery ensures timely access to critical medication, reinforcing the agency's capability to meet patient care needs efficiently. The work scope includes the procurement and delivery of the specified suspension to the performance location in Conshohocken, Pennsylvania. This is a task order under a previously awarded competitive indefinite delivery contract, providing flexibility and rapid response capabilities. The award period is concise, reflecting a single delivery event within a specific timeframe. The underlying long-term contract exemplifies a strategic partnership aimed at enhancing pharmaceutical supply chain operations.

Description

4570807587!QUILLIVANT XR 25 MG/5 ML SUSP 180ML

View original record